Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Pediatrix Medical Group, Inc. (MD) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Pediatrix Medical Group, Inc. (MD) - free report >>
Image: Bigstock
New Strong Sell Stocks for December 23rd
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
SPAR Group (SGRP - Free Report) is a supplier of in-store merchandising and marketing services, and premium incentive marketing services throughout the United States and Canada.The Zacks Consensus Estimate for its current year earnings has been revised 50.0% downward over the last 60 days.
Lifecore Biomedical, Inc. (LFCR - Free Report) is a fully integrated contract development and manufacturing organization which offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials.The Zacks Consensus Estimate for its current year earnings has been revised 38.1 downward over the last 60 days.
Pediatrix Medical Group, Inc. (MD - Free Report) is a company that provides newborn, maternal-fetal, radiology, pediatric cardiology and other pediatric subspecialties physician services in the United States and Puerto Rico.The Zacks Consensus Estimate for its current year earnings has been revised almost 9.6% downward over the last 60 days.
View the entire Zacks Rank #5 List.